Albireo Pharma Stock Target Price and Analyst Consensus

Delisted . USA . 
Stock . Albireo Pharma
ALBODelisted Stock  USD 44.15  0.75  1.67%   
The current analyst and expert consensus on Albireo Pharma is Hold with 5 hold recommendations. The current projected Albireo Pharma target price consensus is 47.33 with 6 analyst opinions. One of the most common ways Albireo Pharma analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Albireo Pharma vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Albireo Pharma. We strongly encourage you to use your own analysis of Albireo Pharma to validate this buy or sell advice. Albireo Pharma recommendation module provides expert sentiment on the projected Albireo Pharma target price to derive its highest and lowest estimates based on target price standard deviation of 6.377. Check out Trending Equities.
  
As of 26th of March 2023, Gross Profit is likely to grow to about 48.7 M, while Profit Margin is likely to drop (0.82) . Albireo Pharma Shareholders Equity is very stable at the moment as compared to the past year. Albireo Pharma reported last year Shareholders Equity of 201.95 Million. As of 26th of March 2023, Total Liabilities is likely to grow to about 156.9 M, while Accumulated Other Comprehensive Income is likely to drop about 916.7 K.

Albireo Pharma Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Albireo target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Albireo target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions7
Lowered Outlook0
Raized Outlook0
Hold
Most Albireo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Albireo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Albireo Pharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Albireo Pharma Target Price Projection

Albireo Pharma's current and average target prices are 44.15 and 47.33, respectively. The current price of Albireo Pharma is the price at which Albireo Pharma is currently trading. On the other hand, Albireo Pharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Albireo Pharma Market Quote on 26th of March 2023

Low Price44.0Odds
High Price44.9Odds

44.15

Target Price

Analyst Consensus On Albireo Pharma Target Price

Low Estimate42.0Odds
High Estimate55.0Odds
Number of Analysts6
Standard Deviation6.377

47.333

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Albireo Pharma and the information provided on this page.

Albireo Pharma Analyst Ratings

Albireo Pharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Albireo Pharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Albireo Pharma's financials, market performance, and future outlook by experienced professionals. Albireo Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Albireo Pharma price targets

Albireo Pharma's stock target price is an estimate of its future price, usually made by analysts. Using Albireo Pharma's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Albireo Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Albireo Pharma's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Albireo Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Albireo Pharma is a key component of Albireo Pharma valuation and have some predictive power on the future returns of a Albireo Pharma.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Albireo Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
30.4444.1257.80
Details
Intrinsic
Valuation
LowReal ValueHigh
26.0539.7353.41
Details
Naive
Forecast
LowNext ValueHigh
35.1848.8662.54
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
43.2643.9744.67
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Albireo Pharma.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Banks Idea
Banks
Invested over 100 shares
Go
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Go
Momentum Idea
Momentum
Invested over 20 shares
Go
Impulse Idea
Impulse
Invested over 200 shares
Go
Banking Idea
Banking
Invested over 40 shares
Go
ESG Investing Idea
ESG Investing
Invested few shares
Go
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 100 shares
Go
Dividend Beast Idea
Dividend Beast
Invested few shares
Go
Check out Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY